| __timestamp | ACADIA Pharmaceuticals Inc. | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 40786000 |
| Thursday, January 1, 2015 | 90804000 | 47876000 |
| Friday, January 1, 2016 | 186456000 | 52035000 |
| Sunday, January 1, 2017 | 255062000 | 55348000 |
| Monday, January 1, 2018 | 265758000 | 65276000 |
| Tuesday, January 1, 2019 | 325638000 | 82720000 |
| Wednesday, January 1, 2020 | 388661000 | 89118000 |
| Friday, January 1, 2021 | 396028000 | 181193000 |
| Saturday, January 1, 2022 | 369090000 | 174078000 |
| Sunday, January 1, 2023 | 402466000 | 184232000 |
Unleashing the power of data
In the competitive world of biotechnology, managing operational expenses is crucial for sustaining growth and innovation. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Veracyte, Inc. and ACADIA Pharmaceuticals Inc. over the past decade.
From 2014 to 2023, ACADIA Pharmaceuticals has seen its SG&A expenses grow by over 1,100%, peaking at approximately $402 million in 2023. In contrast, Veracyte, Inc. has maintained a more conservative growth, with expenses increasing by around 350% to $184 million in the same period.
While ACADIA's aggressive spending reflects its ambitious expansion strategy, Veracyte's more measured approach suggests a focus on sustainable growth. Investors and stakeholders should consider these financial strategies when evaluating the long-term potential of these companies.
Operational Costs Compared: SG&A Analysis of Johnson & Johnson and Veracyte, Inc.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or ACADIA Pharmaceuticals Inc.
SG&A Efficiency Analysis: Comparing Regeneron Pharmaceuticals, Inc. and Veracyte, Inc.
Alnylam Pharmaceuticals, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Insmed Incorporated vs ACADIA Pharmaceuticals Inc.
Sarepta Therapeutics, Inc. vs Veracyte, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing TG Therapeutics, Inc. and Veracyte, Inc.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and ACADIA Pharmaceuticals Inc.
Amneal Pharmaceuticals, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?
CymaBay Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.: SG&A Expense Trends
Veracyte, Inc. vs Merus N.V.: SG&A Expense Trends
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Soleno Therapeutics, Inc. Trends and Insights